- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x BGC: beta-D-glucopyranose(Non-covalent)
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.2: 27 residues within 4Å:- Chain A: G.16, R.19, G.20, I.21, D.40, K.41, C.61, D.62, V.63, N.89, A.90, G.91, L.113, I.139, S.140, S.141, Y.154, K.158, P.184, G.185, N.186, I.187, T.189, P.190, L.191, W.192
- Ligands: F45.4
24 PLIP interactions:24 interactions with chain A- Hydrophobic interactions: A:I.21, A:P.184
- Hydrogen bonds: A:G.16, A:G.18, A:R.19, A:I.21, A:K.41, A:K.41, A:D.62, A:D.62, A:V.63, A:N.89, A:Y.154, A:K.158, A:I.187, A:I.187, A:T.189, A:T.189, A:L.191
- Water bridges: A:G.22, A:D.40, A:D.40, A:N.89
- Salt bridges: A:R.19
NAD.6: 27 residues within 4Å:- Chain B: G.16, R.19, G.20, I.21, D.40, K.41, C.61, D.62, V.63, N.89, A.90, G.91, L.113, I.139, S.140, S.141, Y.154, K.158, P.184, G.185, N.186, I.187, T.189, P.190, L.191, W.192
- Ligands: F45.8
24 PLIP interactions:24 interactions with chain B- Hydrophobic interactions: B:I.21, B:P.184
- Hydrogen bonds: B:G.16, B:G.18, B:R.19, B:I.21, B:K.41, B:K.41, B:D.62, B:D.62, B:V.63, B:N.89, B:Y.154, B:K.158, B:I.187, B:I.187, B:T.189, B:T.189, B:L.191
- Water bridges: B:G.22, B:D.40, B:D.40, B:N.89
- Salt bridges: B:R.19
NAD.10: 27 residues within 4Å:- Chain C: G.16, R.19, G.20, I.21, D.40, K.41, C.61, D.62, V.63, N.89, A.90, G.91, L.113, I.139, S.140, S.141, Y.154, K.158, P.184, G.185, N.186, I.187, T.189, P.190, L.191, W.192
- Ligands: F45.12
23 PLIP interactions:23 interactions with chain C- Hydrophobic interactions: C:I.21, C:P.184
- Hydrogen bonds: C:G.16, C:G.18, C:R.19, C:I.21, C:K.41, C:K.41, C:D.62, C:V.63, C:N.89, C:K.158, C:I.187, C:I.187, C:T.189, C:T.189, C:L.191
- Water bridges: C:G.22, C:D.40, C:D.40, C:T.64, C:N.89
- Salt bridges: C:R.19
NAD.14: 27 residues within 4Å:- Chain D: G.16, R.19, G.20, I.21, D.40, K.41, C.61, D.62, V.63, N.89, A.90, G.91, L.113, I.139, S.140, S.141, Y.154, K.158, P.184, G.185, N.186, I.187, T.189, P.190, L.191, W.192
- Ligands: F45.16
23 PLIP interactions:23 interactions with chain D- Hydrophobic interactions: D:I.21, D:P.184
- Hydrogen bonds: D:G.16, D:G.18, D:R.19, D:I.21, D:K.41, D:K.41, D:D.62, D:V.63, D:N.89, D:K.158, D:I.187, D:I.187, D:T.189, D:T.189, D:L.191
- Water bridges: D:G.22, D:D.40, D:D.40, D:T.64, D:N.89
- Salt bridges: D:R.19
- 4 x NA: SODIUM ION(Non-functional Binders)
NA.3: 4 residues within 4Å:- Chain A: E.50, L.53, P.54, A.56
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:G.55, A:A.56, A:A.56
NA.7: 4 residues within 4Å:- Chain B: E.50, L.53, P.54, A.56
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:L.53, B:G.55, B:A.56
NA.11: 4 residues within 4Å:- Chain C: E.50, L.53, P.54, A.56
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:E.50, C:G.55, C:A.56
NA.15: 4 residues within 4Å:- Chain D: E.50, L.53, P.54, A.56
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:G.55, D:A.56, D:A.56
- 4 x F45: [6-(3,4-dihydroxyphenyl)pyridin-2-yl](4-fluoro-3-hydroxyphenyl)methanone(Non-covalent)
F45.4: 17 residues within 4Å:- Chain A: H.93, P.96, S.141, V.143, Q.148, A.149, Q.150, A.151, Y.154, P.184, G.185, N.186, L.191, W.192, L.195
- Chain C: Y.253
- Ligands: NAD.2
12 PLIP interactions:11 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: A:Y.154, A:W.192, A:W.192, A:W.192, A:L.195, A:L.195, C:Y.253
- Hydrogen bonds: A:H.93, A:S.141, A:S.141, A:Q.148
- pi-Stacking: A:H.93
F45.8: 17 residues within 4Å:- Chain B: H.93, P.96, S.141, V.143, Q.148, A.149, Q.150, A.151, Y.154, P.184, G.185, N.186, L.191, W.192, L.195
- Chain D: Y.253
- Ligands: NAD.6
12 PLIP interactions:1 interactions with chain D, 11 interactions with chain B- Hydrophobic interactions: D:Y.253, B:Y.154, B:W.192, B:W.192, B:W.192, B:L.195, B:L.195
- Hydrogen bonds: B:H.93, B:S.141, B:S.141, B:Q.148
- pi-Stacking: B:H.93
F45.12: 17 residues within 4Å:- Chain A: Y.253
- Chain C: H.93, P.96, S.141, V.143, Q.148, A.149, Q.150, A.151, Y.154, P.184, G.185, N.186, L.191, W.192, L.195
- Ligands: NAD.10
13 PLIP interactions:12 interactions with chain C, 1 interactions with chain A- Hydrophobic interactions: C:Y.154, C:W.192, C:W.192, C:W.192, C:L.195, C:L.195, A:Y.253
- Hydrogen bonds: C:H.93, C:S.141, C:S.141, C:Q.148, C:Y.154
- pi-Stacking: C:H.93
F45.16: 17 residues within 4Å:- Chain B: Y.253
- Chain D: H.93, P.96, S.141, V.143, Q.148, A.149, Q.150, A.151, Y.154, P.184, G.185, N.186, L.191, W.192, L.195
- Ligands: NAD.14
13 PLIP interactions:12 interactions with chain D, 1 interactions with chain B- Hydrophobic interactions: D:Y.154, D:W.192, D:W.192, D:W.192, D:L.195, D:L.195, B:Y.253
- Hydrogen bonds: D:H.93, D:S.141, D:S.141, D:Q.148, D:Y.154
- pi-Stacking: D:H.93
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Badran, M.J. et al., 17beta-hydroxysteroid dehydrogenase type 14 variant S205 in complex with non-steroidal inhibitor. To Be Published
- Release Date
- 2021-07-21
- Peptides
- 17-beta-hydroxysteroid dehydrogenase 14: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x BGC: beta-D-glucopyranose(Non-covalent)
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x NA: SODIUM ION(Non-functional Binders)
- 4 x F45: [6-(3,4-dihydroxyphenyl)pyridin-2-yl](4-fluoro-3-hydroxyphenyl)methanone(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Badran, M.J. et al., 17beta-hydroxysteroid dehydrogenase type 14 variant S205 in complex with non-steroidal inhibitor. To Be Published
- Release Date
- 2021-07-21
- Peptides
- 17-beta-hydroxysteroid dehydrogenase 14: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A